Jean Francois Bergmann

Summary

Country: France

Publications

  1. ncbi [Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): results obtained in France]
    Jean Francois Bergmann
    Universite Paris Diderot, AP HP, Hopital Lariboisiere, Service Médecine Interne A, 75010 Paris, France
    Presse Med 40:e528-37. 2011
  2. ncbi [Orphan diseases : evaluations of new treatments.]
    Veronique Delcey
    Service de Medecine Interne A, Hopital Lariboisiere, 2, rue Ambroise Pare, 75475 Paris Cedex 10, France
    Med Sci (Paris) 21:69-72. 2005
  3. ncbi [Evidence-based medicine in urology]
    J F Bergmann
    Service de Medecine Interne A, Hopital Lariboisiere, 2, rue Ambroise Paré 75475 Paris Cedex 10, France
    Ann Urol (Paris) 41:S80-2. 2007
  4. ncbi [Orphan diseases: evaluations of new treatments]
    J F Bergmann
    Service de Medecine Interne A, Hopital Lariboisiere, 2, rue Ambroise Pare, 75475 Paris 10, France
    Rev Med Interne 28:S202-5. 2007
  5. ncbi Venous thromboembolism risk and prophylaxis in hospitalised medically ill patients. The ENDORSE Global Survey
    Jean Francois Bergmann
    Hopital Lariboisiere, University Paris 7, Paris, France
    Thromb Haemost 103:736-48. 2010
  6. ncbi Intravitreal triamcinolone acetonide for diffuse diabetic macular oedema: 6-month results of a prospective controlled trial
    Francois Audren
    Department of Ophthalmology, Lariboisiere Hospital, University of Paris, Paris, France
    Acta Ophthalmol Scand 84:624-30. 2006
  7. ncbi Intravitreal triamcinolone acetonide for diffuse diabetic macular edema: phase 2 trial comparing 4 mg vs 2 mg
    Francois Audren
    Department of Ophthalmology, Hopital Lariboisiere, Assistance Publique Hopitaux de Paris, Universite Paris, Paris, France
    Am J Ophthalmol 142:794-99. 2006
  8. ncbi Aspirin alters arterial function in patients with chronic heart failure treated with ACE inhibitors: a dose-mediated deleterious effect
    Christophe Meune
    Internal Medicine, Hospital Lariboisiere, Paris, France
    Eur J Heart Fail 5:271-9. 2003
  9. ncbi Low molecular weight heparin for the prevention of deep venous thrombosis: a suitable monitoring in elderly patients?
    Isabelle Mahe
    Service Médecine A, Hopital Lariboisiere, Paris, France
    Pathophysiol Haemost Thromb 32:134-6. 2002
  10. ncbi Elderly medical patients treated with prophylactic dosages of enoxaparin: influence of renal function on anti-Xa activity level
    Isabelle Mahe
    Internal Medicine Department A, Lariboisiere Hospital, Paris, France
    Drugs Aging 24:63-71. 2007

Detail Information

Publications65

  1. ncbi [Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): results obtained in France]
    Jean Francois Bergmann
    Universite Paris Diderot, AP HP, Hopital Lariboisiere, Service Médecine Interne A, 75010 Paris, France
    Presse Med 40:e528-37. 2011
    ..Information about the variation in the risk for venous thromboembolism (VTE) and in prophylaxis practices in France and around the world is scarce...
  2. ncbi [Orphan diseases : evaluations of new treatments.]
    Veronique Delcey
    Service de Medecine Interne A, Hopital Lariboisiere, 2, rue Ambroise Pare, 75475 Paris Cedex 10, France
    Med Sci (Paris) 21:69-72. 2005
    ..Although these rules may be relaxed in orphan diseases, they have to maintain the standard of therapeutic efficiency. double dagger...
  3. ncbi [Evidence-based medicine in urology]
    J F Bergmann
    Service de Medecine Interne A, Hopital Lariboisiere, 2, rue Ambroise Paré 75475 Paris Cedex 10, France
    Ann Urol (Paris) 41:S80-2. 2007
    ..Intention to treat is also a quality terion. Finally, the therapeutic class effect does not exist; therefore, the efficacy of inoma any new drug must be proven...
  4. ncbi [Orphan diseases: evaluations of new treatments]
    J F Bergmann
    Service de Medecine Interne A, Hopital Lariboisiere, 2, rue Ambroise Pare, 75475 Paris 10, France
    Rev Med Interne 28:S202-5. 2007
    ..Although these rules may be relaxed in orphan diseases, they have to maintain the standard of therapeutic efficiency...
  5. ncbi Venous thromboembolism risk and prophylaxis in hospitalised medically ill patients. The ENDORSE Global Survey
    Jean Francois Bergmann
    Hopital Lariboisiere, University Paris 7, Paris, France
    Thromb Haemost 103:736-48. 2010
    ..These data support the necessity to improve implementation of available guidelines for evaluating VTE risk and providing prophylaxis to hospitalised medical patients...
  6. ncbi Intravitreal triamcinolone acetonide for diffuse diabetic macular oedema: 6-month results of a prospective controlled trial
    Francois Audren
    Department of Ophthalmology, Lariboisiere Hospital, University of Paris, Paris, France
    Acta Ophthalmol Scand 84:624-30. 2006
    ..To evaluate prospectively the efficacy and safety of one intravitreal injection of 4 mg triamcinolone acetonide for refractory diffuse diabetic macular edema...
  7. ncbi Intravitreal triamcinolone acetonide for diffuse diabetic macular edema: phase 2 trial comparing 4 mg vs 2 mg
    Francois Audren
    Department of Ophthalmology, Hopital Lariboisiere, Assistance Publique Hopitaux de Paris, Universite Paris, Paris, France
    Am J Ophthalmol 142:794-99. 2006
    ..To prospectively compare the efficacy and safety of 4 vs 2 mg intravitreal triamcinolone acetonide (TA) injection for diabetic macular edema...
  8. ncbi Aspirin alters arterial function in patients with chronic heart failure treated with ACE inhibitors: a dose-mediated deleterious effect
    Christophe Meune
    Internal Medicine, Hospital Lariboisiere, Paris, France
    Eur J Heart Fail 5:271-9. 2003
    ..By inhibiting prostaglandin synthesis, aspirin can interfere with both arterial functional and angiotensin-converting enzyme inhibitor (ACEI) properties and be deleterious in chronic heart failure (CHF)...
  9. ncbi Low molecular weight heparin for the prevention of deep venous thrombosis: a suitable monitoring in elderly patients?
    Isabelle Mahe
    Service Médecine A, Hopital Lariboisiere, Paris, France
    Pathophysiol Haemost Thromb 32:134-6. 2002
    ..Our findings question the opportunity to monitor aXa in elderly patients receiving 4000 IU enoxaparin as antithrombotic prophylaxis...
  10. ncbi Elderly medical patients treated with prophylactic dosages of enoxaparin: influence of renal function on anti-Xa activity level
    Isabelle Mahe
    Internal Medicine Department A, Lariboisiere Hospital, Paris, France
    Drugs Aging 24:63-71. 2007
    ..The safety and optimal use of prophylactic treatment with low-molecular-weight heparins in elderly patients with impaired renal function remain undefined...
  11. ncbi Interaction between acetaminophen and warfarin in adults receiving long-term oral anticoagulants: a randomized controlled trial
    Qian Zhang
    Unité de Recherches Thérapeutiques Service de Médecine Interne A, Hopital Lariboisiere, 2 rue Ambroise Pare, 75010, Paris, France
    Eur J Clin Pharmacol 67:309-14. 2011
    ..We investigated whether acetaminophen, given at 2 g/day and 3 g/day might potentiate the anticoagulant effect of warfarin...
  12. ncbi Effect of widely used combinations of antiretroviral therapy on liver CYP3A4 activity in HIV-infected patients
    Stephane Mouly
    Unit of Therapeutic Research, Department of Internal Medicine, Lariboisiere Hospital, Paris, France
    Br J Clin Pharmacol 62:200-9. 2006
    ..To evaluate the effects of combined antiretroviral drugs (HAART) on liver CYP3A4 activity using the [(14)C-N-methyl]-erythromycin breath test (ERMBT)...
  13. ncbi Amoxicillin/clavulanic acid-warfarin drug interaction: a randomized controlled trial
    Qian Zhang
    University of Paris VII Denis Diderot, Therapeutic Research Unit, Department of Internal Medicine, Lariboisiere Hospital, Paris, France
    Br J Clin Pharmacol 71:232-6. 2011
    ..To investigate whether an interaction exists between amoxicillin/clavulanic acid (amoxiclav) and warfarin in patients treated with stable oral anticoagulant therapy...
  14. ncbi Thromboprophylaxis in medical patients: focus on France
    Jean Francois Bergmann
    Service Médecine Interne A, Hopital Lariboisiere, Paris, France j f
    Semin Thromb Hemost 28:51-5. 2002
    ..Guidelines are urgently needed to encourage French physicians to target thromboprophylaxis for medical patients who are genuinely at high risk of thromboembolic disease and to prescribe the appropriate dose and duration of therapy...
  15. ncbi The [14C-N-methyl]-erythromycin breath test dosimetry complies with the French regulations for radiation safety
    Cécile Salvat
    Department of Nuclear Medicine, Lariboisiere Hospital, Paris, France
    Fundam Clin Pharmacol 17:349-53. 2003
    ..The 14C-ERMBT is safe and complies with the European regulations regarding the administration of 14C-labelled compounds in humans. It can therefore be used in clinical research in France without any particular safety requirement...
  16. ncbi Defining the role of calcium channel antagonists in heart failure due to systolic dysfunction
    Isabelle Mahe
    Service Médecine A, Hopital Lariboisiere, Paris, France
    Am J Cardiovasc Drugs 3:33-41. 2003
    ....
  17. ncbi Improving HIV infection management using antiretroviral plasma drug levels monitoring: a clinician's point of view
    Philippe Clevenbergh
    Infectious Diseases and Internal Medicine Department, Hopital Lariboisiere, Paris, France
    Curr HIV Res 2:309-21. 2004
    ..We also highlight the benefits and limits of this tool as an adjunct in the care of HIV-infected patients...
  18. ncbi D-dimer can predict survival in patients with chronic atrial fibrillation
    Isabelle Mahe
    Department of Internal Medicine, Lariboisiere University Hospital, Paris, France
    Blood Coagul Fibrinolysis 15:413-7. 2004
    ..It may contribute to the risk stratification and perhaps to the choice of the antithrombotic therapy in high-risk patients with elevated DD...
  19. ncbi Pharmacokinetic-pharmacodynamic modeling of the effect of triamcinolone acetonide on central macular thickness in patients with diabetic macular edema
    Francois Audren
    Ophthalmology Department, Hopital Lariboisiere, Universite Paris 7, Paris, France
    Invest Ophthalmol Vis Sci 45:3435-41. 2004
    ..To develop a population model capable of describing the profile of the effect of intravitreal triamcinolone acetonide in the treatment of diabetic diffuse macular edema...
  20. ncbi Efficacy and safety of three ophthalmic inserts for topical anaesthesia of the cornea. An exploratory comparative dose-ranging, double-blind, randomized trial in healthy volunteers
    Isabelle Mahe
    Unité de recherches thérapeutiques, Hopital Lariboisiere, 2 Rue A Paré 75010 Paris, France
    Br J Clin Pharmacol 59:220-6. 2005
    ..Cataract surgery requires prolonged anaesthesia, concomitant with permanent hydration and lubrication of the cornea, in order to provide a clear view of the operation area...
  21. ncbi Does paracetamol potentiate the effects of oral anticoagulants?: a literature review
    Isabelle Mahe
    Service Médecine A, Hopital Lariboisiere, Paris, France
    Drug Saf 27:325-33. 2004
    ..Such a study is currently ongoing...
  22. ncbi [Proposal of HIV, HBV and HCV targeted screening: short period feasibility study in a free-access outpatient medical structure]
    Caroline Aparicio
    Hopital Lariboisiere, urgences accueil et traitement des urgences, 75010 Paris, France
    Presse Med 41:e517-23. 2012
    ..In France, patients coming from sub-Saharan Africa, French Indies and French Guiana are frequently missed HIV, HBV and HCV diagnosis, despite high prevalence of these infections...
  23. ncbi Interaction between paracetamol and warfarin in patients: a double-blind, placebo-controlled, randomized study
    Isabelle Mahe
    Unité de recherches thérapeutiques, Hopital Lariboisiere, 2, rue Ambroise Pare, 75010 Paris, France
    Haematologica 91:1621-7. 2006
    ..The primary end-point of this study was to investigate whether paracetamol initiation potentiates the anticoagulant effect of warfarin and the mechanism of the interaction...
  24. ncbi Efficacy of early clinical evaluation in predicting direct home discharge of elderly patients after hospitalization in internal medicine
    Nicolas Gambier
    Assistance Publique Hopitaux de Paris, Universite Paris XIII, Service de Medecine Interne, Hopital Avicenne, Bobigny, France
    South Med J 105:63-7. 2012
    ..Is clinical judgment better than functional status, comorbidity, or cognitive function scales in predicting DHD of elderly patients after hospitalization?..
  25. ncbi [Use and monitoring of vitamin K antagonists in everyday medical practice. French results of the international ISAM study of patients with nonvalvular atrial fibrillation]
    Isabelle Mahe
    Service de Medecine Interne A, Clinique des anticoagulants Ile de France, Hopital Lariboisiere, Paris
    Presse Med 35:1797-803. 2006
    ..Bleeding complications of vitamin K antagonist (VKA) therapy are currently the most frequent iatrogenic event in France...
  26. ncbi Management of oral anticoagulant in clinical practice: a retrospective study of 187 patients
    Isabelle Mahe
    Department of Internal Medicine, Lariboisiere University Hospital, Paris, France
    J Gerontol A Biol Sci Med Sci 59:1339-42. 2004
    ....
  27. ncbi Inadequate therapeutic response to a recommended antituberculosis fixed-dose combination regimen in an overweight patient with Mycobacterium bovis infection
    Celia Lloret-Linares
    Department of Internal Medicine A, Lariboisiere Hospital, Paris, France
    Ann Pharmacother 47:e4. 2013
    ..To report a case of an overweight man with lymph node tuberculosis due to Mycobacterium bovis, a part of the Mycobacterium tuberculosis complex, treated with fixed-dose combination (FDC) chemotherapy...
  28. ncbi Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation
    Carmelo Lafuente-Lafuente
    Service deGériatrie à orientation Cardiologique etNeurologique, Groupe hospitalier Pitié Salpêtrière Charles Foix, AP HP, UniversitéPierre et Marie Curie Paris 6, Ivry sur Seine, France
    Cochrane Database Syst Rev 5:CD005049. 2012
    ..AF recurs frequently after restoration of normal sinus rhythm. Antiarrhythmic drugs have been widely used to prevent recurrence, but the effect of these drugs on mortality and other clinical outcomes is unclear...
  29. ncbi Hepatitis E virus infection in HIV-infected patients with elevated serum transaminases levels
    Pierre Sellier
    Unité des Maladies Infectieuses et Tropicales, Service de Medecine Interne A, Hopital Lariboisiere, 2, rue Ambroise Pare, 75010, Paris, France
    Virol J 8:171. 2011
    ..This infection was probably contracted locally. Acute HEV hepatitis can occur in HIV-infected patients but rarely explains cryptogenic hepatitis, at least in an urban HIV population, regardless geographic origin and CD4 counts...
  30. ncbi [What are the criteria for evaluation and prevention of venous thromboembolism?]
    Isabelle Mahe
    Service Médecine A, Hopital Lariboisiere, Paris, France
    Therapie 58:327-31. 2003
    ..These different approaches--with their respective advantages and limitations--will be developed...
  31. ncbi Comparative evaluation of adherence to antiretroviral therapy in sub-Saharan African native HIV-infected patients in France and Africa
    Pierre Sellier
    Service de Medecine Interne A, Hopital Lariboisiere, Paris, France
    Clin Infect Dis 43:654-7. 2006
    ..This was mainly related to self-perceived insufficient support from family members and/or fear of the consequences of disclosure of their HIV infection status to their family...
  32. ncbi Aspirin for the prevention of cardiovascular events in the elderly
    Isabelle Mahe
    Service Médecine A, Hopital Lariboisiere, Paris, France
    Drugs Aging 20:999-1010. 2003
    ..In conclusion, aspirin should only be given for primary and secondary prevention in the elderly after a comprehensive evaluation of an individual patient's thrombotic and haemorrhagic risk has been conducted...
  33. ncbi Long term treatment of atrial fibrillation in elderly patients: a decision analysis
    Carmelo Lafuente-Lafuente
    Service de Medecine A, Hopital Lariboisiere, Assistance Publique Hopitaux de Paris, Université Paris Cité Diderot, Paris, France
    Int J Cardiol 155:102-9. 2012
    ..Atrial fibrillation (AF) is more frequent with age but it is not clear whether, and how, older age should influence therapeutic choice...
  34. ncbi Central nervous system tuberculomas in 23 patients
    Horea Man
    Department of Internal Medicine A, Lariboisiere Hospital, Paris, France
    Scand J Infect Dis 42:450-4. 2010
    ..Results did not contradict the use of a 12-month regimen as currently recommended...
  35. ncbi Risks versus benefits of NSAIDs including aspirin in myocarditis: a review of the evidence from animal studies
    Christophe Meune
    Cardiology Department, Cochin Hospital, Rene Descartes University, Paris, France
    Drug Saf 26:975-81. 2003
    ....
  36. ncbi Antiarrhythmic drugs for maintaining sinus rhythm after cardioversion of atrial fibrillation: a systematic review of randomized controlled trials
    Carmelo Lafuente-Lafuente
    Service de Medecine Interne A, Hopital Lariboisiere, Paris, France
    Arch Intern Med 166:719-28. 2006
    ..We performed a systematic review to determine the effect of long-term treatment with those drugs on death, embolisms, adverse effects, and atrial fibrillation recurrence...
  37. ncbi Pharmacodynamics of a new ophthalmic mydriatic insert in healthy volunteers: potential alternative as drug delivery system prior to cataract surgery
    Stephane Mouly
    Unit of Thepapeutic Research, Lariboisiere Hospital, Paris, France
    Basic Clin Pharmacol Toxicol 98:547-54. 2006
    ....
  38. ncbi Mini-series: I. Basic science. Uncertainty and inaccuracy of predicting CYP-mediated in vivo drug interactions in the ICU from in vitro models: focus on CYP3A4
    Stephane Mouly
    Assistance Publique Hopitaux de Paris, Internal Medicine Department, Lariboisiere Hospital, INSERM U705, CNRS UMR7157, University of Paris VII, Paris, France
    Intensive Care Med 35:417-29. 2009
    ..In addition, the impact and clinical relevance of complexities such as dosing-route dependent effects, multi-site kinetics of drug-metabolizing enzymes and non-CYP determinants of metabolic clearance will be addressed...
  39. ncbi Fosamprenavir/ritonavir in advanced HIV disease (TRIAD): a randomized study of high-dose, dual-boosted or standard dose fosamprenavir/ritonavir in HIV-1-infected patients with antiretroviral resistance
    Jean Michel Molina
    Service des Maladies Infectieuses et Tropicales, Hôpital Saint Louis and University of Paris Diderot, Paris 7, 1 avenue Claude Vellefaux, 75475 Paris Cedex 10, France
    J Antimicrob Chemother 64:398-410. 2009
    ....
  40. ncbi Stable frequency of HIV-1 transmitted drug resistance in patients at the time of primary infection over 1996-2006 in France
    Marie Laure Chaix
    Université Paris Descartes EA 3620, AP HP, Laboratoire de Virologie, CHU Necker Enfants Malades, Paris, France
    AIDS 23:717-24. 2009
    ....
  41. ncbi Thromboxane Antagonism with terutroban in Peripheral Arterial Disease: the TAIPAD study
    J N Fiessinger
    centre d investigation clinique, Hopital Europeen Georges Pompidou, Université Descartes, Paris, France
    J Thromb Haemost 8:2369-76. 2010
    ..Terutroban is a selective prostaglandin endoperoxide (TP) receptor antagonist with antithrombotic, antivasoconstrictive and antiatherosclerotic properties and is currently in development for long-term cardiovascular secondary prevention...
  42. ncbi Sensory impairment in obese patients? Sensitivity and pain detection thresholds for electrical stimulation after surgery-induced weight loss, and comparison with a nonobese population
    Pauline Dodet
    Department of Internal Medicine, Assistance Publique Hopitaux de Paris, Hopital Lariboisiere, Unit of Therapeutic Research, Paris, France
    Clin J Pain 29:43-9. 2013
    ..Obese patients have a high prevalence of painful musculoskeletal disorders that may decrease after massive weight loss. Pain thresholds may be different in obese participants...
  43. ncbi Management of xerostomia in older patients : a randomised controlled trial evaluating the efficacy of a new oral lubricant solution
    Stephane Mouly
    Department of Internal Medicine, Lariboisiere Hospital, Paris, France
    Drugs Aging 24:957-65. 2007
    ..Xerostomia is a subjective sensation of mouth dryness that may frequently occur in older patients...
  44. ncbi Enhanced saquinavir exposure in human immunodeficiency virus type 1-infected patients with diarrhea and/or wasting syndrome
    Hervé Trout
    Laboratoire de Toxicologie et Pharmacologie Clinique, Service de Pharmacie, Hopital Lariboisiere, Paris, France
    Antimicrob Agents Chemother 48:538-45. 2004
    ..This must be evaluated in a long-term period...
  45. ncbi [Treatment trial methodology in internal medicine]
    Isabelle Mahe
    Service de Medecine A, Hopital Lariboisiere, AP HP, Paris
    Presse Med 36:512-8. 2007
    ..This article considers ways to improve the participation of departments of internal medicine to future clinical trials...
  46. ncbi Self-medication: from European regulatory directives to therapeutic strategy
    Jean Francois Bergmann
    Service de Medecine Interne, Hopital Lariboisiere, 2, rue Ambroise Pare, 75475 Paris Cedex 10, France
    Fundam Clin Pharmacol 17:275-80. 2003
    ..It is important for the patient, pharmacist and public health in general to distinguish the efficient and safe self medications from the nonvalidated, nonevaluated alternative medicines...
  47. ncbi [Chronic viral hepatitis and needle liver biopsy: controversy or nonsense?]
    Jean Francois Bergmann
    Service de Medecine Interne A, Clinique Therapeutique, Hopital Lariboisiere, 2, rue Ambroise Pare, 75475 Paris Cedex 10
    Gastroenterol Clin Biol 28:100-1. 2004
  48. ncbi Effects of aspirin and clopidogrel on plasma brain natriuretic peptide in patients with heart failure receiving ACE inhibitors
    Christophe Meune
    Department of Cardiology, Cochin Hospital, Paris, France
    Eur J Heart Fail 9:197-201. 2007
    ..By inhibiting prostaglandins, aspirin may be deleterious in heart failure (HF) and/or may counteract angiotensin-converting enzyme (ACE) inhibitor efficacy. Conversely, clopidogrel has no effect on prostaglandin metabolism...
  49. ncbi Pilot study examining the frequency of several gene polymorphisms involved in morphine pharmacodynamics and pharmacokinetics in a morbidly obese population
    Celia Lloret Linares
    Department of Nutrition and Endocrinology, Assistance Publique Hopitaux de Paris, Pitie Salpetriere Hospital, Paris, France
    Obes Surg 21:1257-64. 2011
    ..A118G polymorphism in patients undergoing gastric bypass surgery are needed...
  50. ncbi Circadian fluctuations of macular edema in patients with morning vision blurring: correlation with arterial pressure and effect of light deprivation
    Michel Paques
    Ophthalmology Departments of the Fondation Ophtalmologique Rothschild, Paris, France
    Invest Ophthalmol Vis Sci 46:4707-11. 2005
    ..This study explored the causes of vision fluctuations in patients with chronic macular edema...
  51. ncbi [Follow-up brain imaging after strokes in internal medicine: frequently requested but rarely used for diagnosis or treatment]
    Aku Sewonou
    Service de Medecine A, Hopital Lariboisiere, Paris
    Presse Med 36:1364-70. 2007
    ..To assess the interest of a second computed tomography (CT) scan of the brain during hospitalization of stroke patients in an internal medicine department and study the characteristics of these patients...
  52. ncbi Factors associated with virological response in HIV-infected patients failing antiretroviral therapy: a prospective cohort study
    S Fournier
    Department of Infectious Diseases, Saint Louis Hospital, Assistance Publique, Hopitaux de Paris, Paris, France
    HIV Med 6:129-34. 2005
    ..To assess the antiviral response to optimized therapy following genotypic resistance testing and to identify factors associated with virological response in HIV-1-infected patients failing antiretroviral therapy...
  53. ncbi Tinzaparin and enoxaparin given at prophylactic dose for eight days in medical elderly patients with impaired renal function: a comparative pharmacokinetic study
    Isabelle Mahe
    Service Médecine Interne A, Hopital Lariboisiere, 2, rue Ambroise Pare, Paris, France
    Thromb Haemost 97:581-6. 2007
    ..Trials based on clinical end points should be conducted to evaluate the clinical relevance of these observations...
  54. ncbi Development of sarcoidosis following completion of treatment for hepatitis C with pegylated interferon-{alpha}2a and ribavirin: a case report and literature review
    Albéric Rembrandt Gayet
    Emergency Department, Assistance Publique Hopitaux de Paris, Lariboisiere Hospital, Paris, France
    Clin Med Res 8:163-7. 2010
    ..Pathophysiological mechanisms involved in the development of antiviral therapy-induced sarcoidosis are discussed...
  55. ncbi Skin lightening and its complications among African people living in Paris
    Antoine Petit
    Dermatology Service, Hopital Saint Louis, Paris, France
    J Am Acad Dermatol 55:873-8. 2006
    ..Complications caused by skin lightening practices have not been systematically studied in Europe...
  56. ncbi Gefitinib-phenytoin interaction is not correlated with the C-erythromycin breath test in healthy male volunteers
    Stephanie Chhun
    Assistance Publique Hopitaux de Paris, Lariboisiere Hospital, 75475 Paris Cedex 10, France
    Br J Clin Pharmacol 68:226-37. 2009
    ..We aimed to describe the pharmacokinetic interaction between phenytoin, a potent CYP3A4 and P-glycoprotein (P-gp) (ABCB1) inducer, and gefitinib, a CYP3A4, CYP2D6 and P-gp substrate...
  57. ncbi [Reading a clinical trial report]
    J F Bergmann
    Service de Medecine Interne, Hopital Lariboisiere, Paris
    Rev Prat 50:838-45. 2000
    ..Respect of the reading rules is necessary to assess the reliability of the conclusions, in order to promote evidence-based practice...
  58. ncbi Oral ganciclovir systemic exposure is enhanced in HIV-infected patients with diarrhea and weight loss
    S Mouly
    Department of Internal Medicine, Lariboisiere Hospital and Laboratory of Pharmacology, La Salpetriere Hospital, Paris, France
    J Acquir Immune Defic Syndr 24:344-51. 2000
    ..To determine whether diarrhea and intestinal malabsorption during HIV infection alter oral ganciclovir systemic exposure...
  59. ncbi Switching the nucleoside reverse transcriptase inhibitor backbone to tenofovir disoproxil fumarate + emtricitabine promptly improves triglycerides and low-density lipoprotein cholesterol in dyslipidaemic patients
    M A Valantin
    Department of Infectious Diseases, AP HP, Pitie Salpetriere Hospital, Paris, France
    J Antimicrob Chemother 65:556-61. 2010
    ..To assess the impact of switching to tenofovir disoproxil fumarate + emtricitabine on lipid parameters...
  60. ncbi Lack of effect of a low-molecular-weight heparin (nadroparin) on mortality in bedridden medical in-patients: a prospective randomised double-blind study
    I Mahe
    Service Médecine A, AP HP, Hopital Lariboisiere, 2, rue Ambroise Pare, 75010, Paris, France
    Eur J Clin Pharmacol 61:347-51. 2005
    ....
  61. ncbi [Quality in health care. What quality? Judged by which criteria? By whom? How?]
    J F Bergmann
    Service de Medecine Interne A, Hopital Lariboisiere, 2 rue Ambroise Pare, 75475 Paris, France
    Therapie 56:99-102. 2001
    ..These recommendations have to change gradually to be adapted to medical progress and evidence-based medicine...
  62. ncbi Increased oral ganciclovir bioavailability in HIV-infected patients with chronic diarrhoea and wasting syndrome--a population pharmacokinetic study
    S Mouly
    Department of Internal Medicine, Lariboisiere Hospital, 75475 Paris Cedex 10, France
    Br J Clin Pharmacol 51:557-65. 2001
    ....
  63. ncbi Effects of acetorphan, an antidiarrhoeal enkephalinase inhibitor, on oro-caecal and colonic transit times in healthy volunteers
    J F Bergmann
    Clinique Therapeutique, Hopital Lariboisiere, Paris, France
    Aliment Pharmacol Ther 6:305-13. 1992
    ..In addition, we show that the sulphasalazine and radiopaque markers methods can be simultaneously applied in the same study...
  64. ncbi Effect of the thromboxane prostaglandin receptor antagonist terutroban on arterial thrombogenesis after repeated administration in patients treated for the prevention of ischemic stroke
    C Bal dit Sollier
    Institut des Vaisseaux et du Sang, Hôpital Lariboisière AH HP and Université Paris 7, Paris, France
    Cerebrovasc Dis 28:505-13. 2009
    ..The antithrombotic, antiplatelet and endothelial activity of terutroban, a specific thromboxane prostaglandin receptor antagonist, was assessed in patients previously treated with aspirin for the prevention of ischemic stroke...
  65. ncbi Paracetamol: a haemorrhagic risk factor in patients on warfarin
    I Mahe
    Unité de recherches thérapeutiques, Hopital Lariboisiere, AP HP, 2 rue Ambroise Pare, 75010 Paris, France
    Br J Clin Pharmacol 59:371-4. 2005
    ..To quantify the effect of paracetamol on the anticoagulant effect of warfarin under normal clinical conditions...